Quantcast

J&J to Stop Selling Transvaginal Mesh: More than 1,000 Lawsuits Pending

June 7, 2012

J&J´s Ethicon announced that it will stop marketing the majority of its Transvaginal Mesh products, as published in Reuters and MedPageToday, on June 5th 2012. The products being discontinued are TVT Secur, Prosima, Prolift and Prolift+M. Transvaginal surgical mesh is used to treat pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI).There are more than 1,000 lawsuits pending against Ethicon, Inc. by patients alleging organ damage and other injuries from the implants. On February 7th, 2012 the U.S. Judicial Panel on Multidistrict litigation (JPML) issued an order consolidating three transvaginal mesh litigations into a single proceeding to be heard in the Southern District of West Virginia. Ethicon, Inc. (MDL No. 2327) is among the defendants. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Transvaginal Mesh severe adverse events. [http://www.attorneyone.com/transvaginal-surgical-mesh-lawsuit/ .

San Diego, CA (PRWEB) June 07, 2012

The media spotlight is often a double-edged sword. No one knows this better than women who suffer from Trasvaginal Mesh severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

J&J´s Ethicon announced that it will stop marketing the majority of its Transvaginal Mesh products, as published in Reuters and MedPageToday, on June 5th 2012. The products being discontinued are TVT Secur, Prosima, Prolift and Prolift+M. Transvaginal surgical mesh is used to treat pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI). There are more than 1,000 lawsuits pending against Ethicon, Inc. by patients alleging organ damage and other injuries from the implants.

According to court documents, on April 3rd, 2012, a Minnesota woman, Stacey Pangborn, filed a lawsuit in the U.S. District Court for the District of Maryland (case no. 1:2012cv01018) alleging that she suffered serious complications as a result of her use of a transvaginal mesh device. Defendants are device manufacturer Ethicon and its parent company, Johnson & Johnson. On February 7th, 2012 the U.S. Judicial Panel on Multidistrict litigation (JPML) issued an order consolidating three transvaginal mesh litigations into a single proceeding to be heard in the Southern District of West Virginia. Ethicon, Inc. (MDL No. 2327) is among the defendants.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Transvaginal Mesh severe complications, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Transvaginal Mesh remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On July 13, 2011 an FDA Safety Communication update was issued to inform the medical community and patients that serious complications associated with surgical mesh for transvaginal repair of POP are not rare. According to the FDA´s literature review, “adverse events associated with transvaginally placed mesh can be life-altering for some women”.

AttorneyOne.com has further information on Transvaginal Mesh lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/6/prweb9578053.htm.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/6/prweb9583074.htm


Source: prweb



comments powered by Disqus